|
Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Poole EM, Robinson M, Gold R. Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study. Mult Scler Relat Disord. 2019 Jun;31:157-164. doi: 10.1016/j.msard.2019.03.022. Epub 2019 Mar 30. PubMed PMID: 31005729.
AÑO: 2019; IF: 2.889
|
31005729
|
Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Erratum in: Lancet. 2018 Nov 17;392(10160):2170. PubMed PMID: 29576505.
AÑO: 2018; IF: 59.102
|
|
Hernández Clares R, Sánchez Pedreño P, García Vazquez E, Carreón Guarnizo E, Meca Lallana JE. Aggressive cutaneous leishmaniasis in a patient with multiple sclerosis treated with fingolimod. Neurologia. 2018 Jun;33(5):348-349. doi: 10.1016/j.nrl.2017.01.021. Epub 2017 May 20. English, Spanish. PubMed PMID: 28535923.
AÑO: 2018; IF: 2.038
|
|
Ramió-Torrentà L, Álvarez-Cermeño JC, Arroyo R, Casanova-Estruch B, Fernández O, García-Merino JA, Hernández MA, Izquierdo G, Martínez-Yélamos S, Meca J, Moral E, Olascoaga J, Prieto JM, Saiz A. A guide to treating gait impairment with prolonged-release fampridine (Fampyra(®)) in patients with multiple sclerosis. Neurologia. 2018 Jun;33(5):327-337. doi: 10.1016/j.nrl.2015.11.013. Epub 2016 Feb 10. Review. English, Spanish. PubMed PMID: 26873645.
AÑO: 2018; IF: 2.038
|
|
Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Ginestal R, Martinez-Gines ML, Arroyo R, Rodriguez-Antiguedad A. [Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)]. Rev Neurol. 2018 Jul 1;67(1):15-27. Review. Spanish. PubMed PMID: 29923596.
AÑO: 2018; IF: 0.485
|